drugset / Trial / NCT05996588

Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP

NCT05996588

Phase 4 Completed 86 enrolled Sindh Institute of Urology and Transplantation
RandomizedParallel-groupOpen-labelTreatment

Summary

After approval of ethical committee of Sindh Institute of Urology \& Transplantation (SIUT), 86 patients were enrolled for the elective endoscopic retrograde cholangiopancreatography (ERCP). Randomization was done by a computer-generated randomization table. Patients were divided in two groups based on agents used for the research study. Both the groups were induced by injection midazolam 0.06 mg/kg body weight and injection nalbuphine 0.1 mg/kg body weight. In group A, anesthesia was maintained by Sevoflurane inhalation via nasal prongs with oxygen to achieve minimum alveolar concentration (MAC) approximately 0.25%. Whereas, in Group B propofol infusion at 50 ug/Kg/min started for maintenance of anaesthesia. Ketamine 0.5mg/kg intravenously was used to rescue the sedation level in both groups

Timeline

Start
2022-01-05
Primary completion
2022-11-25
Completion
2022-11-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 50 ug/kg Intravenous
Subject Sevoflurane Other / unclassified 4 % Inhaled
Subject Sevoflurane Other / unclassified 5 % Inhaled

Indications

No indication recorded.